Selective inhibitors for MMP-2 tested in a multitude of diseases may be a plausible alternative in the treatment of HF, but the safety profile, possible adverse effects, and clinical results must be taken into account [110,111,112,113,114,115]. The gene discussed is MMP2; the disease is hydrops fetalis.